EE719 Impact of Stage at Cancer Diagnosis on Total Healthcare Costs: A National Population-Based Study Using England Individual-Level Patient Data
D.R. Jones(Office of Rail Regulation), Ewan Gray(University of Edinburgh), Sophie José(NHS England), Robert A. Cherry(Insight Healthcare), Katie Spencer(University of Leeds), Sara Hiom(Cancer Research Horizons), Brian Rous(NHS Digital), Craig J. Pearson(Insight Healthcare), Guy Baily(Insight Healthcare)
Cited by 0
Related Papers
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
|AIDS|2014|597
The expanding role of primary care in cancer control
|The Lancet Oncology|2015|544
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
|Journal of Hepatology|2015|172
Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
|The Journal of Infectious Diseases|2014|102